6Danning C L, Boumpas D T. Commonly used disease-modifying antirheumatic drugs in the treatment of inflammatory arthritis:an update on mechanisms of action [J]. Clin Exp Rheumatol, 1998, 16(5): 595-604.
7Lee C K, Lee E Y, Chung S M, et al. Effects of disease-modifying antirheumatic drugs and antiinflammatory cytokines on human osteoclastogenesis through interaction with receptor activator of nuclear factor kappa B, osteoprolegerin, and receptor activator of nuclear factor kappaB ligand [J]. Arthritis Rheum, 2004, 50(12): 383l-3843.
8Setoguchi N, Takamura N, Fujita K, et al. A diclofenac suppository-nabumetone combination therapy for arthritic pain relief and a monitoring method for the diclofenac binding capacity of HSA site II in rheumatoid arthritis [J]. Biopharm Drug Dispos, 2013, 34(2): 125-136.
